DTNA (Dystrobrevin alpha) Antibody (YA8141)
(Synonyms: D18S892E; DRP3; DTN; DTN-A; LVNC1)DTNA (Dystrobrevin alpha) Antibody (YA8141) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to DTNA (Dystrobrevin alpha).
-
Host:
Mouse
-
Isotype:
IgG2a
-
Application:
WB, ICC/IF, FC
-
Reactivity :
Human, Mouse, Rat
-
Formulation:
Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
-
Conjugation:
Non-conjugated
Applications
| Application |
WB
WB: Western Blot
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
FC
FC: Flow Cytometry
|
|---|---|---|---|
| Dilution Ratio | 1:500-2000 | 1:100-250 | 1:100 |
Product Details
DTNA (Dystrobrevin alpha) Antibody (YA8141) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to DTNA (Dystrobrevin alpha).
-
Host Mouse
-
Clonality Monoclonal
-
Species ReactivityHuman, Mouse, Rat
-
Calculated Molecular Weight Predicted band size: 58.7 kDa
Full length human recombinant protein of human DTNA produced in HEK293T cell.
Endogenous
Affinity purified
Non-conjugated
Unmodified
IgG2a
Product Properties
-
Appearance
Liquid
-
Formulation
Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
DTNA may be involved in the formation and stability of synapses as well as being involved in the clustering of nicotinic acetylcholine receptors
-
Subcellular Localization
Cytoplasm,Synapse,Cell membrane
-
Expression
Tissue_Specificity: Highly expressed in brain, skeletal and cardiac muscles, and expressed at lower levels in lung, liver and pancreas. Isoform 2 is not expressed in cardiac muscle. Isoform 7 and isoform 8 are only expressed in muscle -
Isoforms & Post-Translational Modification
Q9Y4J8 has 17 isomers: Q9Y4J8-1: 83901 Da (predicted); Q9Y4J8-2: 77653 Da (predicted); Q9Y4J8-3: 65123 Da (predicted); Q9Y4J8-4: 64720 Da (predicted); Q9Y4J8-5: 58874 Da (predicted); Q9Y4J8-6: 43621 Da (predicted); Q9Y4J8-7: 42394 Da (predicted); Q9Y4J8-8: 22108 Da (predicted); Q9Y4J8-9: 41991 Da (predicted); Q9Y4J8-10: 44169 Da (predicted); Q9Y4J8-11: 50417 Da (predicted). Q9Y4J8-12: 36993 Da (predicted); Q9Y4J8-13: 77250 Da (predicted); Q9Y4J8-14: 78064 Da (predicted); Q9Y4J8-15: 82211 Da (predicted); Q9Y4J8-16: 58472 Da (predicted); Q9Y4J8-17: 86781 Da (predicted).
Phosphorylation of DTN-1 on tyrosine kinase substrate domain present in the C-terminus -
Subunit
Interacts with dystrophin, utrophin and the syntrophins SNTA1, SNTB1, SNTB2, SNTG1 and SNTG2
-
SwissProt ID
-
Synonyms
D18S892E; DRP3; DTN; DTN-A; LVNC1
Documentation